Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone 34I8P-2EC9Q) SynExpress T7-mCh-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR294)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone 34I8P-2EC9Q). We employs the pUC (T7-mCherry-c-Jun-KpnI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
mouse
Target
CCL2
Clone
34I8P-2EC9Q
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
mCherry
Promoter
T7
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pUC
Transformation Accuracy
0.91
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.